– UK, London –  McBride Plc (LON: MCB), announces the appointment of Jeffrey Nodland as a Non-Executive Director with immediate effect.

John Coleman, Chairman of McBride, said: “We are delighted that Jeff has agreed to join us at McBride. His extensive experience in the household and personal care industry, as well as private label and contract manufacturing, will bring additional relevant experience to McBride and prove invaluable to the Board in our future discussions.”

About Jeff Nodland

Jeff has extensive experience in consumer chemicals manufacturing businesses including both private label and contract manufacturing activities. He was most recently President and CEO of KIK Custom Products, one of North America’s largest independent manufacturers of consumer packaged goods, where between February 2008 and January 2019 he led the turnaround and growth of the business both organically and via acquisition.

Previously, Jeffrey held senior positions at speciality chemical businesses including Hexion Speciality Chemicals, Inc., McWhorter Technologies and The Valspar Corporation, with responsibility for activities at a number of speciality chemical plants in western and central Europe, including the UK, Belgium, Italy and Germany.

Jeffrey is currently an independent non-executive director of EcoSynthetix, a developer and manufacturer of bio-based polymers for the wood composite and paper industry, which is listed on the Toronto Stock Exchange, and a board member of Augsburg University, Minneapolis. He is a US citizen.

Jeffrey will become a member of the Nomination, Remuneration and Audit Committees.

For more information: http://www.mcbride.co.uk

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Comments are closed.